Agape ATP Net Income
| ATPC Stock | 3.96 -0.48 -10.81% |
Momentum
Impartial
Oversold | Overbought |
As of the 16th of March 2026, Agape ATP registers 3.96 per share in market pricing. Volatility and momentum metrics display mean deviation of 14.75, and Risk Adjusted Performance of 0.0437. Quantitative signals are calculated from volatility clustering and momentum shifts. Relative strength metrics are assessed within peer group data.
Fiscal trend analysis indicates Total Revenue is set to increase significantly relative to last year. Agape ATP filed Total Revenue of 1.52 Million for the preceding year. As of last month (February 2026), Gross Profit is projected to grow to approximately 897.8 K, while Pretax Profit Margin is moving higher toward -2.05 . Agape ATP Total Revenue | 1.65 Million |
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.0685 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -2.2 M | -2.1 M | |
| Net Loss | -2.3 M | -2.2 M | |
| Net Loss | -2.2 M | -2.3 M | |
| Net Loss | -2.24 | -2.13 | |
| Net Income Per E B T | 0.90 | 0.78 |
Agape | Net Income | Build AI portfolio with Agape Stock |
Analyzing Agape ATP's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Agape ATP's current valuation and future prospects.
Latest Agape ATP's Net Income Growth Pattern
Below is the plot of the Net Income of Agape ATP over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Agape ATP financial statement analysis. It represents the amount of money remaining after all of Agape ATP operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Agape ATP's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agape ATP's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported -2.49 M | 10 Years Trend |
|
Net Income |
| Timeline |
Agape Net Income Regression Statistics
| Arithmetic Mean | -939,274 | |
| Geometric Mean | 579,187 | |
| Coefficient Of Variation | -105.01 | |
| Mean Deviation | 880,428 | |
| Median | -300,000 | |
| Standard Deviation | 986,290 | |
| Sample Variance | 972.8B | |
| Range | 2.9M | |
| R-Value | -0.78 | |
| Mean Square Error | 411.5B | |
| R-Squared | 0.60 | |
| Significance | 0.0002 | |
| Slope | -151,722 | |
| Total Sum of Squares | 15.6T |
Agape Net Income History
Other Fundumenentals of Agape ATP
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Agape ATP Net Income component correlations
Agape Net Income Driver Correlations
A sound financial model for Agape ATP must account for the correlations between Agape ATP's key financial indicators, including Net Income. Because Agape ATP's accounts are all linked within its financial reports, a correlation-based approach provides a practical way to assess.
Click cells to compare fundamentals
Earnings Share -12.50 | Revenue Per Share | Quarterly Revenue Growth 0.119 | Return On Assets | Return On Equity |
Investors evaluate Agape ATP using market value and book value, each describing different facets of the business. Agape ATP's market capitalization is 4.44 M. A P/B ratio of 0.19 suggests Agape ATP trades near or below book value. Enterprise value stands at 4.56 M. Value and price for Agape ATP are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that Agape ATP's intrinsic value and market price are different measures derived from different inputs. For Agape ATP, key inputs include a P/B ratio of 0.19, a profit margin of -1.83%, ROE of -21.58%, and revenue of 1.32 M. Agape ATP's trading price represents the transaction level agreed by market participants.
What if' Analysis
What-if analysis for Agape ATP is essentially a historical sensitivity test that shows how changes in the investment horizon could have altered realized return, drawdown, and timing outcomes. The stronger interpretation comes from comparing realized return, risk, and path dependency instead of focusing only on the best historical outcome.
| 12/16/2025 |
| 03/16/2026 |
If you invested 0.00 in Agape ATP on December 16, 2025 and closed the position today, you would produce 0.00 in cumulative gains. In total, that is a 0.0% total return in Agape ATP in aggregate across 90 days. Agape ATP is often compared with DDC Enterprise, Wing Yip, Bridgford Foods, Borealis Foods, Laird Superfood, Local Bounti, and Farmer Bros based on sector and business overlap. This provides context for relative positioning. Agape ATP operates as a Stock listed security. More
Upside and Downside Indicators for Agape ATP Summary
Upside and downside indicators for Agape ATP summarize momentum balance and potential range context for the stock. The indicators are presented as neutral context for price dynamics.
| Downside Deviation | 19.58 | |||
| Information Ratio | 0.0439 | |||
| Maximum Drawdown | 190.33 | |||
| Value At Risk | -25.00 | |||
| Potential Upside | 55.71 |
Market Risk Indicators for Agape ATP Snapshot
Market risk indicators summarize volatility and return dispersion for Agape ATP. The metrics rely on historical prices to describe variability over time.| Risk Adjusted Performance | 0.0437 | |||
| Jensen Alpha | 1.35 | |||
| Total Risk Alpha | 2.93 | |||
| Sortino Ratio | 0.0666 | |||
| Treynor Ratio | 0.5957 |
The mean reversion framework for Agape ATP is built on the premise that markets are not perfectly efficient and that prices periodically overshoot their intrinsic value in both directions.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0437 | |||
| Market Risk Adjusted Performance | 0.6057 | |||
| Mean Deviation | 14.75 | |||
| Semi Deviation | 18.13 | |||
| Downside Deviation | 19.58 | |||
| Coefficient Of Variation | 2339.53 | |||
| Standard Deviation | 29.69 | |||
| Variance | 881.67 | |||
| Information Ratio | 0.0439 | |||
| Jensen Alpha | 1.35 | |||
| Total Risk Alpha | 2.93 | |||
| Sortino Ratio | 0.0666 | |||
| Treynor Ratio | 0.5957 | |||
| Maximum Drawdown | 190.33 | |||
| Value At Risk | -25.00 | |||
| Potential Upside | 55.71 | |||
| Downside Variance | 383.43 | |||
| Semi Variance | 328.66 | |||
| Expected Short fall | -22.43 | |||
| Skewness | 2.65 | |||
| Kurtosis | 15.86 |
Agape ATP Backtested Returns
Agape ATP reflects an extremely high risk exposure across the analytical window. It has a Sharpe Ratio of 0.0595, which indicates that 0.0595 units of return per unit of risk over the last 3 months. We identified twenty-eight technical indicators supporting this volatility profile. Please analyze metrics such as mean deviation of 14.75, and risk-adjusted performance of 0.0437 to evaluate coherence across risk measures. Agape ATP holds a performance score of 4 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 2.11, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Agape ATP will likely underperform. Use Agape ATP value at risk, expected short fall, and the relationship between the total risk alpha and daily balance of power, to analyze future returns on Agape ATP.
Auto-correlation | 0.19 |
Very weak predictability
Agape ATP shows very weak predictability when comparing price series from 16th of December 2025 to 30th of January 2026 against from 30th of January 2026 to 16th of March 2026. A strong serial relationship would imply that Agape ATP's recent trajectory contains information about its near-term direction. With a serial correlation of 0.19, over 19.0% of Agape ATP's price variation is attributable to patterns in preceding intervals.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 1.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Agape Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income | 39,492.2 |
Based on the recorded statements, Agape ATP reported net income of -2.49 Million. This is 100.22% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 100.44% higher than that of the company.
Agape Net Income Peer Comparison
Comparing Agape ATP to its peers on Net Income is a core component of equity analysis that helps investors assess relative value. A notably favorable Agape ATP's Net Income compared to competitors can indicate undervaluation or a stronger competitive position.Agape ATP is currently under evaluation for net income relative to top peers.
Agape ATP ESG Sustainability
Companies with higher ESG scores, such as Agape ATP, achieve better valuations than less sustainable peers. Although Agape ATP's sustainability reporting is voluntary, it signals governance quality and helps investors assess long-term business resilience.Environmental | Governance | Social |
Agape Fundamentals
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | -1.83 % | ||||
| Operating Margin | -1.62 % | ||||
| Current Valuation | 4.56 M | ||||
| Shares Outstanding | 1 M | ||||
| Shares Owned By Insiders | 52.57 % | ||||
| Shares Owned By Institutions | 0.64 % | ||||
| Number Of Shares Shorted | 40.95 K | ||||
| Price To Book | 0.19 X | ||||
| Price To Sales | 2.99 X | ||||
| Revenue | 1.32 M | ||||
| Gross Profit | 782.31 K | ||||
| EBITDA | -2.35 M | ||||
| Net Income | -2.49 M | ||||
| Total Debt | 362.78 K | ||||
| Book Value Per Share | 22.83 X | ||||
| Cash Flow From Operations | -2.73 M | ||||
| Short Ratio | 0.23 X | ||||
| Earnings Per Share | -12.50 X | ||||
| Number Of Employees | 16 | ||||
| Beta | 0.28 | ||||
| Market Capitalization | 4.44 M | ||||
| Total Asset | 3.24 M | ||||
| Retained Earnings | -9.52 M | ||||
| Working Capital | 1.66 M | ||||
| Net Asset | 3.24 M |
Financial Metrics, Fundamentals & Methodology
Agape ATP reports annual revenue of 1.32 M, a profit margin of -1.83%, ROE of -21.58%, an operating margin of -1.62%. A detailed fundamental review of Agape ATP evaluates revenue consistency, margin structure, and capital efficiency. Return-based metrics measure structural efficiency across cycles. Agape ATP financial statements indicate revenue of 1.32 M, EPS loss of 12.5, negative operating margin of 1.62%.
Reported values for Agape ATP are derived from periodic company reporting and market reference feeds and then standardized by Macroaxis analytics. Refresh times depend on source availability. Statement-level metrics reflect company-reported GAAP or IFRS formats for the relevant filing period.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.More Resources for Agape Stock Analysis
Understanding Agape ATP typically begins with financial statements and long-term trend review. Ratio analysis helps investors evaluate Agape ATP Stock operating efficiency and financial trajectory. Highlighted below are reports that provide context for Agape ATP Stock: Earnings Share -12.50 | Revenue Per Share | Quarterly Revenue Growth 0.119 | Return On Assets | Return On Equity |
Investors evaluate Agape ATP using market value and book value, each describing different facets of the business. Agape ATP's market capitalization is 4.44 M. A P/B ratio of 0.19 suggests Agape ATP trades near or below book value. Enterprise value stands at 4.56 M. Value and price for Agape ATP are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that Agape ATP's intrinsic value and market price are different measures derived from different inputs. For Agape ATP, key inputs include a P/B ratio of 0.19, a profit margin of -1.83%, ROE of -21.58%, and revenue of 1.32 M. Agape ATP's trading price represents the transaction level agreed by market participants.